According to the monitoring report publicized on 9 Dec., Livzon Group (Ningxia) Pharmaceutical Co., Ltd. (Livzon Ningxia) completed L-phenylalanine production line technical transformation project.
Project overview
- Nature: Technical transformation
- Location: Pingluo Industrial Park, Shizuishan City, Ningxia Hui Autonomous Region
- Total investment: USD0.65 million (RMB4.70 million)
- Construction content: The existing L-phenylalanine production line, with a capacity of 13,000 t/a, underwent technical transformation to enable the production of tryptophan and L-isoleucine.
- Product plan:
- L-phenylalanine production was maintained for 183 days, the capacity reduced from 13,000 t/a to 9,000 t/a.
- Tryptophan, L-isoleucine, and L-phenylalanine are produced alternately for 147 days, with three production schemes throughout the year:
- Producing solely 4,000 t/a of tryptophan；
- Simultaneously producing 2,000 t/a of tryptophan and 2,000 t/a of L-isoleucine；
- Producing solely 4,000 t/a of L-isoleucine.
- Main raw materials: The production of 4,000 t/a of tryptophan requires approximately 23,000 t/a of glucose (purchased).
- Labor quota: No new employees
- Progress:
- Start construction: March 2024
- Completion: Jun. 2024
- On-site environmental monitoring: Jul. 2024
You can get more information on China’s corn deep-processing industry by checking out NK Corn Deep-Processing China News or email us at contact@nkmarketresearch.com.
